|
1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Lorincz AT: Cancer diagnostic classifiers
based on quantitative DNA methylation. Expert Rev Mol Diagn.
14:293–305. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Kanwal R and Gupta S: Epigenetics and
cancer. J Appl Physiol (1985). 109:598–605. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Huang Y, Nayak S, Jankowitz R, Davidson NE
and Oesterreich S: Epigenetics in breast cancer: What's new? Breast
Cancer Res. 13:2252011. View
Article : Google Scholar : PubMed/NCBI
|
|
5
|
Spitzwieser M, Holzweber E, Pfeiler G,
Hacker S and Cichna-Markl M: Applicability of HIN-1, MGMT and
RASSF1A promoter methylation as biomarkers for detecting field
cancerization in breast cancer. Breast Cancer Res. 17:1252015.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
van Roy F and Berx G: The cell-cell
adhesion molecule E-cadherin. Cell Mol Life Sci. 65:3756–3788.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Drees F, Pokutta S, Yamada S, Nelson WJ
and Weis WI: Alpha-catenin is a molecular switch that binds
E-cadherin-beta-catenin and regulates actin-filament assembly.
Cell. 123:903–915. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yamada S, Pokutta S, Drees F, Weis WI and
Nelson WJ: Deconstructing the cadherin-catenin-actin complex. Cell.
123:889–901. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Andrews JL, Kim AC and Hens JR: The role
and function of cadherins in the mammary gland. Breast Cancer Res.
14:2032012. View
Article : Google Scholar : PubMed/NCBI
|
|
10
|
De Leeuw WJ, Berx G, Vos CB, Peterse JL,
Van de Vijver MJ, Litvinov S, Van Roy F, Cornelisse CJ and
Cleton-Jansen AM: Simultaneous loss of E-cadherin and catenins in
invasive lobular breast cancer and lobular carcinoma in situ. J
Pathol. 183:404–411. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Berx G, Cleton-Jansen AM, Strumane K, de
Leeuw WJ, Nollet F, van Roy F and Cornelisse C: E-cadherin is
inactivated in a majority of invasive human lobular breast cancers
by truncation mutations throughout its extracellular domain.
Oncogene. 13:1919–1925. 1996.PubMed/NCBI
|
|
12
|
Derksen PW, Liu X, Saridin F, van der
Gulden H, Zevenhoven J, Evers B, van Beijnum JR, Griffioen AW, Vink
J, Krimpenfort P, et al: Somatic inactivation of E-cadherin and p53
in mice leads to metastatic lobular mammary carcinoma through
induction of anoikis resistance and angiogenesis. Cancer Cell.
10:437–449. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Acs G, Lawton TJ, Rebbeck TR, LiVolsi VA
and Zhang PJ: Differential expression of E-cadherin in lobular and
ductal neoplasms of the breast and its biologic and diagnostic
implications. Am J Clin Pathol. 115:85–98. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Benton G, Crooke E and George J: Laminin-1
induces E-cadherin expression in 3-dimensional cultured breast
cancer cells by inhibiting DNA methyltransferase 1 and reversing
promoter methylation status. FASEB J. 23:3884–3895. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Cheng CW, Wu PE, Yu JC, Huang CS, Yue CT,
Wu CW and Shen CY: Mechanisms of inactivation of E-cadherin in
breast carcinoma: Modification of the two-hit hypothesis of tumor
suppressor gene. Oncogene. 20:3814–3823. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Edge SB and Compton CC: The American Joint
Committee on Cancer: The 7th edition of the AJCC cancer staging
manual and the future of TNM. Ann Surg Oncol. 17:1471–1474. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Elston CW and Ellis IO: Pathological
prognostic factors in breast cancer. I. The value of histological
grade in breast cancer: Experience from a large study with
long-term follow-up. Histopathology. 41:154–161. 1991.
|
|
18
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Herman JG, Graff JR, Myöhänen S, Nelkin BD
and Baylin SB: Methylation-specific PCR: A novel PCR assay for
methylation status of CpG islands. Proc Natl Acad Sci USA.
93:9821–9826. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Bertolo C, Guerrero D, Vicente F, Cordoba
A, Esteller M, Ropero S, Guillen-Grima F, Martinez-Peñuela JM and
Lera JM: Differences and molecular immunohistochemical parameters
in the subtypes of infiltrating ductal breast cancer. Am J Clin
Pathol. 130:414–424. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Sebova K, Zmetakova I, Bella V, Kajo K,
Stankovicova I, Kajabova V, Krivulcik T, Lasabova Z, Tomka M,
Galbavy S and Fridrichova I: RASSF1A and CDH1 hypermethylation as
potential epimarkers in breast cancer. Cancer Biomark. 10:13–26.
2011.PubMed/NCBI
|
|
22
|
Caldeira JR, Prando EC, Quevedo FC, Neto
FA, Rainho CA and Rogatto SR: CDH1 promoter hypermethylation and
E-cadherin protein expression in infiltrating breast cancer. BMC
Cancer. 6:482006. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Shinozaki M, Hoon DS, Giuliano AE, Hansen
NM, Wang HJ, Turner R and Taback B: Distinct hypermethylation
profile of primary breast cancer is associated with sentinel lymph
node metastasis. Clin Cancer Res. 11:2156–2162. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Tao MH, Mason JB, Marian C, McCann SE,
Platek ME, Millen A, Ambrosone C, Edge SB, Krishnan SS, Trevisan M,
et al: Promoter methylation of E-cadherin, p16 and RAR-β (2) genes
in breast tumors and dietary intake of nutrients important in
one-carbon metabolism. Nutr Cancer. 63:1143–1150. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Nass SJ, Herman JG, Gabrielson E, Iversen
PW, Parl FF, Davidson NE and Graff JR: Aberrant methylation of the
estrogen receptor and E-cadherin 5′ CpG islands increases with
malignant progression in human breast cancer. Cancer Res.
60:4346–4348. 2000.PubMed/NCBI
|
|
26
|
Parrella P, Poeta ML, Gallo AP, Prencipe
M, Scintu M, Apicella A, Rossiello R, Liguoro G, Seripa D, Gravina
C, et al: Nonrandom distribution of aberrant promoter methylation
of cancer-related genes in sporadic breast tumors. Clin Cancer Res.
10:5349–5354. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Horne HN, Sherman ME, Garcia-Closas M,
Pharoah PD, Blows FM, Yang XR, Hewitt SM, Conway CM, Lissowska J,
Brinton LA, et al: Breast cancer susceptibility risk associations
and heterogeneity by E-cadherin tumor tissue expression. Breast
Cancer Res Treat. 143:181–187. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Berx G and van Roy F: Involvement of
members of the cadherin superfamily in cancer. Cold Spring Harb
Perspect Biol. 1:a0031292009. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Tryndyak VP, Beland FA and Pogribny IP:
E-cadherin transcriptional down-regulation by epigenetic and
microRNA-200 family alterations is related to mesenchymal and
drug-resistant phenotypes in human breast cancer cells. Int J
Cancer. 126:2575–2583. 2010.PubMed/NCBI
|
|
30
|
Berletch JB, Phipps SM, Walthall SL,
Andrews LG and Tollefsbol TO: A method to study the expression of
DNA methyltransferases in aging systems in vitro. Methods Mol Biol.
371:81–87. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Plass C and Soloway PD: DNA methylation,
imprinting and cancer. Eur J Hum Genet. 10:6–16. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Denis H, Ndlovu MN and Fuks F: Regulation
of mammalian DNA methyltransferases: A route to new mechanisms.
EMBO Rep. 12:647–656. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Cavusoglu Celebiler A, Sevinc AI, Saydam
S, Canda T, Baskan Z, Kilic Y and Sakizli M: Promoter methylation
and expression changes of CDH1 and P16 genes in invasive breast
cancer and adjacent normal breast tissue. Neoplasma. 57:465–472.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Holm K, Hegardt C, Staaf J,
Vallon-Christersson J, Jönsson G, Olsson H, Borg A and Ringnér M:
Molecular subtypes of breast cancer are associated with
characteristic DNA methylation patterns. Breast Cancer Res.
12:R362010. View
Article : Google Scholar : PubMed/NCBI
|
|
35
|
Pathiraja TN, Stearns V and Oesterreich S:
Epigenetic regulation in estrogen receptor positive breast
cancer-role in treatment response. J Mammary Gland Biol Neoplasia.
15:35–47. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Kominsky SL, Fackler MJ, Lahti-Domenici J,
Polyak K, Sacchi N, Garrett-Mayer E, Argani P and Sukumar S: Very
high frequency of hypermethylated genes in breast cancer metastasis
to the bone, brain and lung. Clin Cancer Res. 10:3104–3109. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Lombaerts M, van Wezel T, Philippo K,
Dierssen JW, Zimmerman RM, Oosting J, van Eijk R, Eilers PH, van de
Water B, Cornelisse CJ and Cleton-Jansen AM: E-cadherin
transcriptional downregulation by promoter methylation but not
mutation is related to epithelial -to- mesenchymal transition in
breast cancer cell lines. Br J Cancer. 94:661–671. 2006.PubMed/NCBI
|
|
38
|
van Horssen R, Hollestelle A, Rens JA,
Eggermont AM, Schutte M and Ten Hagen TL: E-cadherin promotor
methylation and mutation are inversely related to motility capacity
of breast cancer cells. Breast Cancer Res Treat. 136:365–377. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Chao YL, Shepard CR and Wells A: Breast
carcinoma cells re-express E-cadherin during mesenchymal to
epithelial reverting transition. Mol Cancer. 9:1792010. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Droufakou S, Deshmane V, Roylance R, Hanby
A, Tomlinson I and Hart IR: Multiple ways of silencing E-cadherin
gene expression in lobular carcinoma of the breast. Int J Cancer.
92:404–408. 2001. View
Article : Google Scholar : PubMed/NCBI
|
|
41
|
Asgeirsson KS, Jónasson JG, Tryggvadóttir
L, Olafsdóttir K, Sigurgeirsdóttir JR, Ingvarsson S and
Ogmundsdóttir HM: Altered expression of E-cadherin in breast
cancer. patterns, mechanisms and clinical significance. Eur J
Cancer. 36:1098–1106. 2000. View Article : Google Scholar : PubMed/NCBI
|
